The nonprofit generic drug company being formed by a coalition of five large U.S. health systems has yet to produce a single product, but customers already appear to be lining up in anticipation of the first launch.
A new national survey of nearly 750 key stakeholders from hospitals, pharmaceutical companies and payor organizations, conducted by the research firm Reaction Data, found that 90% of hospital and clinic providers, including physicians and pharmacy directors, are